Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Topical treatment 'can be effective'
Clinical studies show that topical treatment alone can be as effective as giving antibiotic tablets.

BSAVA delegates learn how to limit the spread of MRSA/MRSP

MRSA and MRSP present an increasing risk to both animals and humans. Speaking at BSAVA Congress (6-9 April), Dr Anette Loeffler, senior lecturer in veterinary dermatology at the RVC, outlined the infections and discussed the most appropriate control strategies to limit their spread.  

MRSA and MRSP are very different diseases, but they are most often identified from skin and ear infections. While the prognosis is usually very good, they both have zoonotic implications and the growing crisis of antibiotic resistance means that treatment options are limited.

MRSA is primarily a human pathogen, also known as the human hospital bug. Around 10 years ago, MRSA could be found in almost every human hospital in the UK. While rates have fallen dramatically, it is still one of the most important hospital-associated bacterial pathogens. In pets, MRSA tends to be a spillover from human hospitals.

MRSP is the veterinary equivalent of MRSA and has the potential to become a veterinary nosocomial pathogen. "This is where we've all got responsibility to nip it in the bud," said Anette. MRSP infections appear to be increasing in animals, especially dogs. The infection transmits to pets by direct contact between animals. Healthy animals showing no signs of MRSP infection are likely to be the main source of the bacterium.

The risk of contracting MRSA or MRSP increases through long stays in clinics, invasive procedures, use of implants and the prolonged use of invasive equipment such as a catheter. Veterinary staff have a higher occupational risk of carrying MRSA. Veterinary practices are also likely to harbour more resistant bacteria than the home, but only if hygiene practices are below standard.

During the lecture, Anette gave delegates some take-home tips to prevent and control MRSA and MRSP infection amongst pets and within veterinary practices. She stressed that owner education, maintaining good practice hygiene and the responsible use of antimicrobials are key to preventing the spread of infection.

Anette also highlighted the importance of hand washing using staphylococcal agents and to follow the manufacturer's protocols of cleaning and disinfection. Infected animals shed the virus into the environment, so they should be treated as contagious patients, she said. Hospitalised patients must be isolated or barrier nursed and appointments should be scheduled for the end of the day.

Her final tip was to recognise signs of MRSA and MRSP in patients early and to encourage them to follow up with topical treatment (washing). Clinical studies show that topical treatment alone can be as effective as giving antibiotic tablets. But Anette stressed that this requires an element of owner compliance and understanding.

"All of us need to work very hard to convince owners that topical treatment can be effective," she concluded.

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.